Abstract
The influence of the antiinflammatory, prostaglandin-inhibitor naproxen on endothelial cell loss after cataract surgery was studied. A total of 26 patients received the drug, and 27 comprised a control group. The cell loss, estimated 1 yr after surgery, was significantly lower in the naproxen-treated group than in the control group.